Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase 1b/2 Basket Study to Assess the Safety and Efficacy of AsiDNA™ in Combination with Olaparib in Participants with Recurrent Solid Tumors

NCT05700669 is registered in ClinicalTrials.gov with Valerio Therapeutics as lead sponsor.

NCT NCT05700669
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05700669 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase 1b/2 Basket Study to Assess the Safety and Efficacy of AsiDNA™ in Combination with Olaparib in Participants with Recurrent Solid Tumors
Lead sponsor
Valerio Therapeutics
Phase
Phase 1/2
Overall status
Completed
Start date
February 20, 2023
Completion date
October 31, 2023
Enrollment
3 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

breast cancer, metastatic castration-resistant prostate cancer, recurrent epithelial ovarian cancer